What is the evidence for oxygenation during kidney preservation for transplantation in 2021? A scoping review
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..
PURPOSE: The main objective of static cold storage is to reduce cellular metabolic demands to extend the period of ischaemia prior to transplantation. Hypothermia does not halt metabolism and the absence of oxygen causes a cellular shift toward anaerobic respiratory pathways. There is emerging evidence that the introduction of oxygenation during organ preservation may help ameliorate the degree of ischaemia reperfusion injury and improve post-transplantation outcomes. This review aims to appraise and summarise all published literature that utilises oxygenation to improve kidney preservation for purposes of transplantation.
METHODS: We performed a scoping review of the literature using the bibliographic databases Embase and MEDLINE. The final date for searches was 20 March 2021. All research studies included were those that reported oxygen delivery during kidney preservation as well as providing a description of the oxygenation technique.
RESULTS: 17 human and 48 animal studies met the inclusion criteria. The oxygen delivery methods investigated included hypothermic oxygenated machine perfusion (HOPE), oxygen carriers, two-layer method, venous systemic persufflation, hyperbaric oxygenation, normothermic machine perfusion and sub-normothermic machine perfusion. The COMPARE trial was the only study carried out with the most methodological robustness being a randomised, double blind, controlled, phase III trial that investigated the efficacy of HOPE versus HMP.
CONCLUSION: A variety of studies reflect the evolution of oxygenation with useful lessons and encouraging outcomes. The first in human studies investigating HOPE and oxygen carriers are most robustly investigated strategies for oxygenation during kidney preservation and are, therefore, the best clinical references.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
World journal of urology - 40(2022), 9 vom: 25. Sept., Seite 2141-2152 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mesnard, B [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 01.09.2022 Date Revised 09.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00345-021-03757-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329753126 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329753126 | ||
| 003 | DE-627 | ||
| 005 | 20231225205816.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00345-021-03757-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1099.xml |
| 035 | |a (DE-627)NLM329753126 | ||
| 035 | |a (NLM)34432136 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mesnard, B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a What is the evidence for oxygenation during kidney preservation for transplantation in 2021? A scoping review |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.09.2022 | ||
| 500 | |a Date Revised 09.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. | ||
| 520 | |a PURPOSE: The main objective of static cold storage is to reduce cellular metabolic demands to extend the period of ischaemia prior to transplantation. Hypothermia does not halt metabolism and the absence of oxygen causes a cellular shift toward anaerobic respiratory pathways. There is emerging evidence that the introduction of oxygenation during organ preservation may help ameliorate the degree of ischaemia reperfusion injury and improve post-transplantation outcomes. This review aims to appraise and summarise all published literature that utilises oxygenation to improve kidney preservation for purposes of transplantation | ||
| 520 | |a METHODS: We performed a scoping review of the literature using the bibliographic databases Embase and MEDLINE. The final date for searches was 20 March 2021. All research studies included were those that reported oxygen delivery during kidney preservation as well as providing a description of the oxygenation technique | ||
| 520 | |a RESULTS: 17 human and 48 animal studies met the inclusion criteria. The oxygen delivery methods investigated included hypothermic oxygenated machine perfusion (HOPE), oxygen carriers, two-layer method, venous systemic persufflation, hyperbaric oxygenation, normothermic machine perfusion and sub-normothermic machine perfusion. The COMPARE trial was the only study carried out with the most methodological robustness being a randomised, double blind, controlled, phase III trial that investigated the efficacy of HOPE versus HMP | ||
| 520 | |a CONCLUSION: A variety of studies reflect the evolution of oxygenation with useful lessons and encouraging outcomes. The first in human studies investigating HOPE and oxygen carriers are most robustly investigated strategies for oxygenation during kidney preservation and are, therefore, the best clinical references | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Hyperbaric Oxygenation | |
| 650 | 4 | |a Hypothermic oxygenated machine perfusion | |
| 650 | 4 | |a Kidney transplantation | |
| 650 | 4 | |a Normothermic Machine Perfusion | |
| 650 | 4 | |a Organ preservation | |
| 650 | 4 | |a Oxygen | |
| 650 | 4 | |a Oxygen carrier | |
| 650 | 4 | |a Venous systemic oxygen persufflation | |
| 650 | 7 | |a Oxygen |2 NLM | |
| 650 | 7 | |a S88TT14065 |2 NLM | |
| 700 | 1 | |a Ogbemudia, A E |e verfasserin |4 aut | |
| 700 | 1 | |a Karam, G |e verfasserin |4 aut | |
| 700 | 1 | |a Dengu, F |e verfasserin |4 aut | |
| 700 | 1 | |a Hackim, G |e verfasserin |4 aut | |
| 700 | 1 | |a Rigaud, J |e verfasserin |4 aut | |
| 700 | 1 | |a Blancho, G |e verfasserin |4 aut | |
| 700 | 1 | |a Drouin, S |e verfasserin |4 aut | |
| 700 | 1 | |a Timsit, M O |e verfasserin |4 aut | |
| 700 | 1 | |a Branchereau, J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World journal of urology |d 1988 |g 40(2022), 9 vom: 25. Sept., Seite 2141-2152 |w (DE-627)NLM07484959X |x 1433-8726 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2022 |g number:9 |g day:25 |g month:09 |g pages:2141-2152 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00345-021-03757-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2022 |e 9 |b 25 |c 09 |h 2141-2152 | ||